Position in ACET
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$159,287
+$28,535 QoQ
Shares Held
18,436
-4.0% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 56 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,552,102 across 424 Biotechnology names. ACET ranks #334 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ACET
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $159,287 | 18,436 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $130,752 | 19,200 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $118,444 | 14,067 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $113,702 | 140,373 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $85,627 | 140,373 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $105,981 | 140,373 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $135,034 | 140,369 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $161,591 | 112,216 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $487,074 | 402,541 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,023,694 | 435,615 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $438,640 | 232,085 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $315,648 | 230,401 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $588,057 | 241,999 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,511,607 | 262,432 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,382,232 | 266,469 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,426,977 | 240,997 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,266,895 | 223,760 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,077,873 | 204,200 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,965,446 | 169,551 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,357,879 | 173,199 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,884,530 | 183,142 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $339,896 | 25,986 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||